Abbott Laboratories (ABT) just dropped its guidance — is this a short-term stumble or a long-term opportunity? In this episode of Am I Catching a Falling Knife?, host Dave breaks down Abbott's Q2 earnings surprise, the real impact of fading COVID-19 testing demand, and why China diagnostics might be dragging down this healthcare heavyweight. 💉📉We analyze the numbers, run a DCF valuation, and project a custom fair value — all to find out if ABT is worth the risk. Are analysts right to stay bullish? Or is this knife still falling?⛔ Not financial advice — just cold, calculated narrative.🔔 Subscribe for more breakdowns like this every week.#AbbottLabs #StockAnalysis #ABT #Investing #FallingKnife #DCFValuation #Earnings